A little-known approach to infertility is complicating the White House's IVF push
By Aria Bendix,
NBC News
| 08. 08. 2025
President Donald Trump has nicknamed himself “the fertilization president,” but six months after he formally pledged to expand access to in vitro fertilization, the White House has yet to issue a policy to that end.
Since he campaigned on the issue last year, Trump’s push to support IVF has been complicated by backlash from conservatives and anti-abortion groups who see IVF as unethical, as well as members of the “Make America Healthy Again” movement who view the pharmaceutical industry as having undue influence over fertility care.
Many of these groups have instead suggested that Trump redirect his attention to a little-known holistic approach called restorative reproductive medicine. The underlying philosophy is that doctors can identify and treat the root causes of infertility, often with less invasive and more affordable methods than IVF.
But restorative reproductive medicine isn’t formally recognized as a medical specialty in the U.S. and has not been evaluated as extensively as IVF has. Many fertility doctors worry that holistic methods are being presented to patients as a better alternative to IVF, thereby denying patients access...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...